DRUG PRICE & REIMBURSEMENT CRITERIA IN THE UK
HTA: WHERE ARE WE AND WHICH WAY WILL WE GO?
THE NEW THERAPEUTIC ASSESSMENTS OF THE AEMPS
ECONOMIC EVALUATION IN ACCESS TO MEDICAL INNOVATION
THE ROLE OF THE AGENCIES FOR HEALTH TECHNOLOGY ASSESSMENT: THE AETSA EXPERIENCE
CURRENT ROLE OF DRUG AND THERAPEUTIC COMMITTEES IN HOSPITALS
PHARMACOVIGILANCE STRATEGIES IN HOSPITALS - THE BELLVITGE UNIVERSITY HOSPITAL EXPERIENCE
PHARMACOVIGILANCE STRATEGIES IN HOSPITALS - THE VIRGEN DEL ROCÍO UNIVERSITY HOSPITAL MODEL
PHARMACOVIGILANCE IN CANTABRIA: PROACTIVE STRATEGIES IN PRIMARY CARE FOR ADDRESSING PATIENT SAFETY ISSUES
POST-AUTHORISATION SAFETY STUDY
EARLY DEVELOPMENT OF NOVEL ANTI-CANCER STRATEGIES IN THE ERA OF PERSONALIZED MEDICINE
COMPARATIVE EFFECTIVENESS RESEARCH: THE INTEGRATION OF RESEARCH INTO CLINICAL PRACTICE
BIOSIMILARS: FROM ANALYTICAL DEVELOPMENT TO POSTAUTHORIZATION STUDIES
SPANISH CLINICAL RESEARCH NETWORK (SCREN)
UICEC-HUVR-IBIS: A FOUR YEARS EXPERIENCE IN A CLINICAL TRIAL UNIT SUPPORTING COORDINATED NON COMMERCIAL RESEARCH
THE FEASIBILITY OF MULTI-DATABASE PHARMACOEPIDEMIOLOGICAL STUDIES: EXPERIENCE OF THE PROTECT PROJECT
ENCEPP. PROMOTING PHARMACOEPIDEMIOLOGICAL RESEARCH
A RANDOMIZED, OPEN-LABEL, CROSSOVER CLINICAL TRIAL TO EVALUATE THE ABSOLUTE ORAL BIOAVAILABILITY OF SILIBILIN (SIL-FARMA-01)
MULTICENTRIC OSTEOARTHRITIS INTERVENTION STUDY WITH SYSADOA (MOVES): EFFECTS OF COMBINED GLUCOSAMINE HYDROCHLORIDE AND CHONDROITIN SULFATE VS. CELECOXIB FOR PAINFUL KNEE OSTEOARTHRITIS
PHARMACODYNAMICS OF NICOTINE FROM SECOND-GENERATION ELECTRONIC CIGARETTE
NON-COMMERCIAL ADVANCED THERAPY MEDICINAL PRODUCTS (ATMPS): IS IT POSSIBLE TO PERFORM A MULTICENTRE CLINICAL TRIAL INVOLVING DIFFERENT EUROPEAN PRODUCTION CENTRES?
THE ROLE OF KILLER IG-LIKE RECEPTORS (KIR) AND HLA CLASS I PROFILES IN IDIOSYNCRATIC HEPATOTOXICITY
EFFECTS OF POLYMORPHIMS OF CYP3A5 AND ABCB1 GENES ON CHRONIC NEPHROPATHY. COHORT STUDY
INTERVENTION TO IMPROVE SAFETY INCIDENTS RELATED TO MEDICATION IN PATIENTS WITH COMPLEX NEEDS (PCN) OR WITH ADVANCED CHRONIC CONDITIONS (ACC)
CHRONICITY IN IDIOSYNCRATIC DRUG-INDUCED LIVER INJURY (DILI): CAUSATIVE DRUGS AND RISK FACTSORS
FACIAL PARALYSIS AND VACCINES. A CASE NON-CASE APPROACH IN VIGIBASE AND IN VAERS
PERIOPERATIVE MANAGEMENT AND OUTCOMES OF PATIENTS TREATED WITH ANTITHROMBOTICS ADMITTED FOR HIP FRACTURE SURGERY
EFFECTIVENESS, SAFETY AND COSTS OF STROKE PREVENTION IN NON-VALVULAR ATRIAL FIBRILLATION PATIENTS (ESC-FA STUDY). DESCRIPTION OF COHORTS AND BASELINE CHARACTERISTICS OF PATIENTS
COST-EFFECTIVENESS ANALYSIS OF TRIPLE THERAPY WITH PEGINTERFERON, RIBAVIRIN, AND BOCEPREVIR FOR THE TREATMENT OF CHRONIC HEPATITIS C VIRUS GENOTYPE 1 WITH SEVERE FIBROSIS UNDER ‘REAL-LIFE’ CONDITIONS
SYSTEMATIC APPROACH TO THE DESCRIPTION OF THE EVIDENCE SUPPORTING EMA REGULATORY OPINIONS ON ORPHAN MEDICINAL PRODUCTS
POPULATION MODELING OF NEUTROPHILS DYNAMIC IN CANCER PATIENTS TREATED WITH PM060184
A RANDOMIZED CLINICAL TRIAL TO EVALUATE THE EFFECTIVENESS OF A MULTI-MODAL INTERVENTION IN FRAIL AND PREFRAIL OLDER PEOPLE WITH TYPE 2 DIABETES ON FRAILTY AND QUALITY OF LIFE: THE MIDFRAIL STUDY
POSTOPERATIVE BLEEDING PREVENTION IN MASSIVE BONE TUMOUR RESECTION: A MULTICENTRIC, RANDOMIZED, PARALLEL, CONTROLLED TRIAL TO ASSESS THE EFFICACY OF TRANEXAMIC ACID VERSUS EVICEL® AND USUAL HAEMOSTASIS [PROTOCOL],
MONOSODIUM URATE CRYSTAL INDUCED MACROPHAGE INFLAMMATION IS ATTENUATED BY CHONDROITIN SULFATE: PRE-CLINICAL MODEL FOR GOUT PROPHYLAXIS?
CHONDROPROTECTIVE ACTIVITY OF A COMBINATION OF CHONDROITIN SULFATE, GLUCOSAMINE AND A NATURAL INGREDIENT RICH IN HYALURONIC ACID
RELATION BETWEEN WAIST CIRCUNFERENCE AND PLASMA DIABETES BIOMARKERS IN A VENEZUELAN POPULATION WITH NEWLY DIAGNOSED METABOLIC SYNDROME
EFFICACY AND SAFETY OF SOFOSBUVIR IN THE TREATMENT OF HEPATITIS C VIRUS INFECTION
DIRECT ORAL ANTICOAGULANTS AND RISK OF GASTROINTESTINAL BLEEDING: A META-ANALYSIS
BIOMARKERS ASSOCIATED WITH OBESITY AND OVERWHEIGHT IN A VENEZUELAN POPULATION
THE EFFECTS OF TREATMENT ON DISEASE SYMPTOMS AND PROGRESSION OF STRUCTURAL CHANGES IN KNEE OSTEOARTHRITIS PARTICIPANTS FROM THE OSTEOARTHRITIS INITIATIVE PROGRESSION COHORT
A COLLABORATION BETWEEN PRIMARY CARE AND THE RAMON Y CAJAL HOSPITAL. THE VALUE OF SCREN (SPANISH CLINICAL RESEARCH NETWORK) TO SUPPORT AN INDEPENDENT MULTICENTER CLINICAL TRIAL WITH MEDICAL PRODUCTS
ASSESSMENT OF THE LEVEL OF UNDERSTANDING OF INFORMED CONSENT (IC) FROM THE PATIENTS PARTICIPATING IN CLINICAL TRIALS (CT)
CLINICAL TRIALS AUTHORISED BY THE SPANISH AGENCY OF MEDICINES AND MEDICAL DEVICES IN 2013. CONCLUSIONS OF AEMPS AND RESEARCH ETHICS COMMITTEE
TO BE OR NOT TO BE HEALTHY VOLUNTEER IN CLINICAL TRIALS. THAT IS THE QUESTION
THE IRIS PROJECT ON IBODUTANT: CLINICAL DEVELOPMENT OF A NEW, FIRST-IN-CLASS INNOVATIVE AGENT FOR THE TREATMENT OF IRRITABLE BOWEL SYNDROME (IBS).
INSULIN RESISTANCE MARKERS AS INDICATORS OF CARDIOVASCULAR RISK IN A POPULATION OF HYPERTENSIVE PATIENTS
BASAL BOLUS VERSUS CONVENTIONAL INSULIN THERAPY FOR NON-CRITICAL MEDICAL INPATIENTS: A RANDOMIZED CONTROLLED TRIAL
PRELIMINARY SAFETY RESULTS OF A DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED, CLINICAL TRIAL WITH THE PROBIOTIC NYADITUM RESAE IN ADULTS WITH OR WITHOUT LATENT TUBERCULOSIS INFECTION
USE OF CLONIDINE AS ADJUNCTIVE TO ANESTHESIA TO REDUCE SURGICAL FIELD BLEEDING IN ENDOSCOPIC NASO-SINUSAL SURGERY: GENERATION OF EFFICACY DATA TO SUPPORT ROUTINE CLINICAL PRACTICE
KNEE OSTEOARTHRITIS PROGRESSION IS PREDICTABLE BY GENETIC POLYMORPHISMS. RESULTS FROM A MULTICENTER ASSOCIATION STUDY
TRANSIENT HICCUPS AFTER INTRAMUSCULAR BETAMETHASONE INJECTION: AN ADVERSE EVENT REPORTED IN A NON-THERAPEUTIC CLINICAL TRIAL
INTERACTIONS BETWEEN SOY EXTRACT AND ALCOHOL
ADVERSE REACTIONS WITH ARIPIPRAZOLE: RELATION WITH GENDER AND PHARMACOKINETICS
EVALUATION OF PROTOCOL DEVIATIONS NOTIFIED TO THE CEIC
TREATING CHRONIC PAIN IN PEOPLE WITH OPIOID IATROGENIC DEPENDENCE
TAP1 AND TAP2 POLYMORPHISMS IN HEPATOTOXICITY INDUCED BY AMOXICILLIN-CLAVULANATE (AC DILI)
COMPARATIVE BIOAVAILABILITY STUDY OF IBUPROFEN LYSINATE AND IBUPROFEN BASE ORAL SUSPENSIONS ADMINISTERED IN HEALTHY VOLUNTEERS
GENDER DIFFERENCES IN BIOAVAILABILITY AND PHARMACOKINETICS OF RASAGILINE
IL-28B POLYMORPHISMS FOR PREDICTION OF RESPONSE TO TREATMENT OF HEPATITIS C WITH INTERFERON AND RIBAVIRIN
ADVERSE DRUG REACTIONS IN HOSPITALIZED PATIENTS: A PROSPECTIVE STUDY OF THEIR INCIDENCE, SERIOUSNESS, COST AND ASSOCIATED FACTORS
ADVERSE DRUG REACTION MONITORING FOR OPIOIDS IN CHRONIC NON-MALIGNANT PAIN
THE ONCOLOGIST IN THE MIST. LIVING WITH THE ERROR OF ESTIMATED GFR (EGFR) IN THE CALCULATION OF CARBOPLATIN DOSES
DIFFERENT SOURCES OF DETECTING (SKIN) ADVERSE DRUG REACTIONS
CITIZENS' PERSPECTIVE ON MEDICINE-RELATED PROBLEMS
PROFILE ADVERSE REACTIONS ASSOCIATED BOCEPREVIR
THERAPEUTIC CONSULTATIONS OF BIOTECHNOLOGICAL DRUGS
ADVERSE DRUG REACCTIONS IN NEONATOLOGY
THERAPEUTIC CONSULTATIONS ON TERATOGENS: RISK INFORMATION OF DRUGS AND PREGNANCY OUTCOMES
ATTITUDES, KNOWLEDGE AND SKILLS OF HOSPITAL REGISTERED NURSES TO REPORT ADVERSE DRUG REACTIONS AND MEDICATION ERRORS
OFF-LABEL USE OF NEW ORAL ANTICOAGULANTS IN ABLATION FOR ATRIAL FIBRILLATION
RISK OF CARDIAC ISCHEMIC EVENTS IN PATIENTS WITH OSTEOARTHRITIS: A CASE-CONTROL STUDY
DRUGS ASSOCIATED HYPONATREMIA HOSPITALIZATION
SUSPICION OF BENIGN INTRACRANIAL HYPERTENSION (BIH) IN GIRL TREATED WITH TRIPTORELIN
PANCREATITIS BY OMEPRAZOLE. AN ADVERSE DRUG REACTION TO CONSIDER FROM A CLINICAL PERSPECTIVE?
INSULIN-DEPENDENT DIABETES MELLITUS SECONDARY TO ASPARAGINASE INDUCED PANCREATITIS
SUICIDE ATTEMPT AND MEDICATIONS. A RETROSPECTIVE CASE-CONTROL STUDY
FIRST REPORT OF AORTITIS POSIBLE RELATED TO DENOSUMAB
ACUTE CONFUSIONAL SYNDROME IN AN ELDERLY TREATED WITH MOXIFLOXACIN: A CASE-REPORT
SHOULD IT BE MANDATORY THE REPORTING OF SERIOUS ADRS IN OTHER DESIGNS OBSERVATIONAL POST AUTHORIZATION STUDIES (EPA-OD)?
ADVERSE REACTIONS TO DRUGS AS A CAUSE OF HOSPITAL ADMISSION HOSPITAL UNIVERSITARIO DE LA PRINCESA - MADRID
EFFICIENCY OF THE CONTROL OF POLYPHARMACY IN PRIMARY CARE IN ELDERLY
FLUORESCENCE-GUIDED SURGERY WITH 5-AMINOLEVULINIC ACID FOR RESECTION OF HIGH GRADE GLIOMA: EFFECTIVENESS AND SAFETY RESULTS OF A PROSPECTIVE COHORT
RISK FACTORS ASSOCIATED WITH PERIOPERATIVE BLEEDING IN PATIENTS TREATED WITH ANTITHROMBOTICS ADMITTED FOR HIP FRACTURE SURGERY
COST OF BIOLOGICAL AGENTS USED IN THE TREATMENT OF AUTOIMMUNE DISEASES IN CÁDIZ DURING 2012
MEASUREMENT OF RENAL FUNCTION WITH A GOLD STANDARD: IMPACT ON DOSE CALCULATION AND COSTS OF EXPENSIVE DRUGS
ADHERENCE TO PHARMACOLOGICAL TREATMENT VERSUS A BACK SCHOOL PROGRAM FOR CHRONIC LOWER BACK PAIN
ASSESSMENT OF INADEQUATE PSYCHODRUGS IN PEDIATRICS
EFFECT OF INADEQUATE DRUG PRESCRIPTION IN ELDERLY PATIENTS IN THE SURGERY DEPARTMENTS OF THE HOSPITAL CLÍNICO SAN CARLOS OF MADRID ON THE HOSPITAL READMISSION
DRUGS INVOLVED IN SUICIDE ATTEMPTS TREATED IN A GENERAL HOSPITAL
OFF LABEL DRUG USE IN PEDIATRIC PATIENTS IN THE COMMUNITY PHARMACY OFFICE
PRESCRIPTION ADEQUACY OF GLP-1 ANALOGUES IN PRIMARY CARE
PRESCRIPTION PATTERNS OF ANTIHYPERTENSIVES IN A COMMUNITY-HEALTH CENTRE IN MEXICO CITY. A DRUG UTILIZATION STUDY
CHANGES IN TREND OF STRONTIUM RANELATE PRESCRIPTION AFTER WARNINGS FROM EUROPEAN MEDICINES AGENCY: A UTILIZATION STUDY IN CANTABRIA PRIMARY CARE
DRUG USE IN INSTITUTIONALIZED PATIENTS: A NEW REGISTER-BASE PROGRAM IN CANTABRIA
EFFECTIVENESS OF 5-AMINOLEVULINIC ACID: COMPARISON DATA BETWEEN A CLINICAL TRIAL AND A DESCRIPTIVE STUDY
IMPACT OF STATE REFORMS ON PHARMACEUTICAL ALLOWANCE ON THE PROTON PUMP INHIBITORS PRESCRIPTION IN GALICIA
COMPASSIONATE USE OF MEDICINAL PRODUCTS: A MULTICENTER STUDY
HOW TO MOTIVE AND GUIDE THE NOVEL INVESTIGATORS
EFFECT OF CHONDROITIN SULPHATE ON PROINFLAMMATORY MEDIATORS AND DISEASE ACTIVITY IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE
ANALYSIS OF THE CALL FOR GRANTS OF HEALTH RESEARCH PROJECTS FROM THE INSTITUTE OF HEALTH CARLOS III: INSTITUT D'INVESTIGACIÓ BIOMÈDICA SANT PAU (IIB SANT PAU) RESULTS AND COMPARISON BETWEEN 2012 AND 2013
ANALYSIS OF THE STUDIES PRESENTED AT THE HOSPITAL GENERAL UNIVERSITARIO DE CIUDAD REAL DURING THE PERIOD 2008-2013
USE OF COMMERCIAL FILMS TO TEACH NON-MEDICAL AND UNDESIRABLE USE OF DRUGS
PERFORMANCE OF A READABILITY TEST TO EVALUATE THE COMPREHENSIBILITY OF A PATIENT HANDBOOK ON CELL THERAPY CLINICAL RESEARCH
APPLICATIONS OF NANOTECHNOLOGY IN MEDICINE (NANOMEDICINE)